Our Pipeline
- HOME
- Our Pipeline
- Pipeline
Pipeline
Our molecular platform-derived regenerative drug candidates target various indications, including incurable wounds, heart diseases, neuronal diseases, vascular diseases, and retinal diseases.
| Code | Indication | Developmental Stage | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Proof-of-concept | Non-clinical | Early phase clinical trial | Late phase clinical trial | Marketing authorization | Post-market surveillance | |||||
| Korea | Global | Korea | Global | Korea | Global | |||||
| PU001 | Diabetic foot ulcer | ● | ||||||||
| RH001 | Acute myocardial infarction | ● | ||||||||
| PN001 | Cerebral infarction | ● | ||||||||
| PN002 | Alzheimer’s disease | ○ | ||||||||
| RR001 | Retinal disease | ○ | ||||||||
| PV001 | Vascular disease | ○ | ||||||||